Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership
Learn More
close
Fred Hutch - Cures Start Here®
Research
Pioneering Scientific Research
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Obliteride
Climb to Fight Cancer
Create Your Own
Log In to Your Fundraiser
Attend an Event
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Submit
Donate
Now
Submit
Research
Pioneering Scientific Research
Research Areas
Research Areas
Behavioral Research
Biostatistics
Cell & Gene Therapy
Cell Biology
Data Science
Diagnostics & Biomarkers
Disease Prevention
Epidemiology
Gene Regulation & Expression
Genetics & Genomics
Global Health
Health Economics
Hematopoietic Transplantation
Immunotherapy
Infectious Diseases
Microbiome
Survivorship
Vaccine Development
Virology
Diseases
Diseases
Autoimmune Diseases
Cancers
COVID-19
Genetic Disorders
Herpes
HIV/AIDS
Divisions
Divisions
Basic Sciences Division
Clinical Research Division
Human Biology Division
Public Health Sciences Division
Vaccine and Infectious Disease Division
Clinical Trials & Studies
Clinical Trials & Studies
Clinical Trials FAQ
Patient Treatment & Support
Patient Treatment & Support
Meet Our Clinicians
Make an Appointment
Patient Stories
Long-Term Follow-Up
Survivorship Program
Cook for Your Life
Faculty & Lab Directory
COVID-19 Clinical Research Center
Office of Education & Training
Institutes, Networks & IRCs
Projects & Studies
Scientific Publications
Shared Resources
Investors & Industry
Collaborating for Cures
Business Development
Business Development
Available Technologies
Collaborations & Spinoffs
Commercialization
Events & Conferences
Team
News
Driving Innovation
Driving Innovation
Shared Facilities
GMP Manufacturing
Team Science
Data-Intensive Bioscience
Contact Us
About Us
Cures Start Here
About The Hutch
About The Hutch
Accountability & Impact
Diversity, Equity & Inclusion
Facilities & Infrastructure
History
Honors & Awards
Institutional Partners & Collaborations
Leadership
Mission & Values
Contact Us
Contact Us
Campus Map
Virtual Campus Visit
Scientific Staff Directory
Global Locations
Careers
Internships
Science Education Outreach (SciEd)
Events and Seminars
For the Media
Ways to Give
Why Your Gift Matters
Give Now
Honor a Loved One
Give Through Your Will
Give Through Your Donor Advised Fund
Donate Cryptocurrency
Give Through Your Foundation
Make a Corporate Gift
Create an Endowment
Fundraise for Fred Hutch
Fundraise for Fred Hutch
Obliteride
Climb to Fight Cancer
Create Your Own
Log In to Your Fundraiser
Attend an Event
Support Our Science
Support Our Science
Greatest Need and Impact
Cancer Research
COVID-19 Research
Immunotherapy, Data Science, and the Steam Plant
Diversity, Equity and Reduction of Health Disparities
Join a Gift Club
Other Ways to Give
Other Ways to Give
Give Monthly
Donate Stock
Give at Work
Donate Your Vehicle
Contact Philanthropy
Careers
News
Contact
Donate Now
Hutch News
Science Spotlight
News Releases
Scientific Publications
For the Media
Media Coverage
Stories tagged chimeric antigen receptor
Results per Page:
20
5
10
20
50
100
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Hutch News - September 26, 2019
Tags
Multiple Myeloma
Transplant and Immunotherapy
Damian Green
Stanley R Riddell
chimeric antigen receptor
genetically engineered t cells
Juno Therapeutics
clinical trials
Clinical Research
american society of hematology
scientific conferences
ASH
ASH 2019
Share
Highlights of Fred Hutch science in 2018
A look back at notable advances in immunotherapy, precision screening and more
Hutch News - December 18, 2018
Tags
immunotherapy
Transplant and Immunotherapy
healthcare economics
health disparities
hutchinson institute for cancer outcomes research
chimeric antigen receptor
chemotherapy
biotechnology
genetic mutation
Colorectal Cancer
UCI Hutchinson Center Cancer Alliance
HIV-AIDS
Tumor specific translational research
Molecular basis of cancer
Vaccine development - Viral cancers
Cancer etiology - prevention - outcomes
AMP study
gene editing
big data
cancer screening
Share
Forbes '30 Under 30' lists Hutch immunotherapy researcher Alex Salter
Grad student on short list of young health care influencers
Hutch News - November 14, 2018
Tags
Good News
Stanley R Riddell
Clinical Research
immunotherapy
Transplant and Immunotherapy
CAR t-cell
chimeric antigen receptor
t cell therapy
Share
Want to make better T-cell therapies? First, figure out how they work.
New study maps out activities, effects of widely used components in cellular immunotherapies
Hutch News - August 21, 2018
Tags
Clinical Research
Stanley R Riddell
Amanda Paulovich
Raphael Gottardo
immunotherapy
Transplant and Immunotherapy
chimeric antigen receptor
t cell therapy
signal pathways
Cancers
Share
Cancer cells BiTE the dust through SMITE-bispecific mediated T cell activation
- from the Walter's and Mehlin's labs, Clinical Research Division
Science Spotlight - May 21, 2018
Tags
Roland Walter
antibodies
chimeric antigen receptor
Share
Tinkering with T cells
How researchers are tweaking engineered immune cells’ cancer-targeting receptors — and why it matters
Hutch News - May 15, 2018
Tags
immunotherapy
Transplant and Immunotherapy
t cell therapy
t cell receptor
chimeric antigen receptor
genetic engineering
Stanley R Riddell
Philip D Greenberg
Clinical Research
Immunology Program
Share
First systematic study of infections after CAR T-cell therapy
“Benchmark” research could help reduce complications of emerging immunotherapy
Hutch News - November 06, 2017
Tags
immunotherapy
Transplant and Immunotherapy
Cameron Turtle
Joshua Hill
CAR t-cell
chimeric antigen receptor
t cell therapy
adoptive t cell therapy
Vaccine and Infectious Disease
Clinical Research
Infectious Diseases
Opportunistic Infections
Share
Mourning the loss of Dr. Oliver 'Ollie' Press
Lymphoma physician-scientist, leader and mentor made lifesaving contributions to the development of targeted cancer therapies
Hutch News - October 02, 2017
Tags
Clinical Research
Oliver Press
Transplant and Immunotherapy
immunotherapy
radioimmunotherapy
chimeric antigen receptor
CAR t-cell
mentoring
Seattle Cancer Care Alliance (SCCA)
UW Medicine
Lymphoma
Share
Fred Hutch Statement Regarding FDA Briefing About CAR T-cell Therapy
Fred Hutch immunotherapy expert comments on FDA staff review of CAR T-cell therapy
Hutch News - July 11, 2017
Tags
oncologic drugs advisory committee
chimeric antigen receptor
u.s. food and drug administration
CAR t-cell
t cell therapy
David G Maloney
Share
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight
Hutch News - June 16, 2017
Tags
immunotherapy
Transplant and Immunotherapy
Clinical Research
Sylvia Lee
Renato Martins
Philip D Greenberg
Michael Jensen
Juno Therapeutics
Adaptive Biotechnologies
chimeric antigen receptor
adoptive t cell therapy
CAR t-cell
tumor infiltrating lymphocyte
checkpoint inhibitors
Lung Cancer
Melanoma
Leukemia
pediatric
Share
Dissolving implant could bring immunotherapy to solid tumors
A biopolymer sponge delivers cancer-shrinking T-cell therapy in preclinical study
Hutch News - April 24, 2017
Tags
Breast Cancer
Pancreatic Cancer
Melanoma
Ovarian Cancer
Clinical Research
Matthias Stephan
chimeric antigen receptor
CAR t-cell
T cell
T lymphocytes
Transplant and Immunotherapy
targeted t cell immunotherapy
Share
Tiny tech reprograms immune cells to fight cancer
Nanoparticles turn immune cells into leukemia-fighting powerhouses while they’re still inside the body
Hutch News - April 17, 2017
Tags
nanotechnology tools
immunotherapy
Transplant and Immunotherapy
targeted t cell immunotherapy
Clinical Research
Matthias Stephan
chimeric antigen receptor
Share
Patients with advanced lymphoma in remission after T-cell therapy
New study: 7 of 11 trial participants who got two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission
Hutch News - September 07, 2016
Tags
immunotherapy
Cameron Turtle
Turtle Lab
non-hodgkin lymphoma
T cell
CAR t-cell
Stanley R Riddell
David G Maloney
chimeric antigen receptor
ASH 2016
Cancer etiology - prevention - outcomes
Transplant and Immunotherapy
Tumor specific translational research
ASH 2017
ASCO 2018
scientific conferences
Share
When do we say cure for cancer?
A loaded word for cancer patients, but researchers view ‘cure’ through lens of statistics
Hutch News - July 08, 2016
Tags
Frederick R Appelbaum
Stanley R Riddell
Rainer Storb
Jean Sanders
immunotherapy
chimeric antigen receptor
t cell therapy
bone marrow transplantation
bone marrow transplant
E Donnall Thomas
Pancreatic Cancer
Leukemia
Lymphoma
graft versus leukemia
Clinical Research
cancer moonshot
Transplant and Immunotherapy
Cancer etiology - prevention - outcomes
Share
93 percent of advanced leukemia patients in remission after immunotherapy
‘Exciting’ but early results from trial of engineered immune cells
Hutch News - April 25, 2016
Tags
immunotherapy
chimeric antigen receptor
CAR t-cell
Leukemia
Acute Lymphoblastic Leukemia
David G Maloney
Cameron Turtle
Stanley R Riddell
ASH 2017
ASCO 2018
ASH 2018
scientific conferences
Share
Unique cancer arising after anti-CD19 CAR-T cell therapy
Science Spotlight - April 18, 2016
Tags
immunotherapy
chimeric antigen receptor
Clinical Research
Cameron Turtle
Stanley R Riddell
Share
Fred Hutchinson Cancer Center
Hutch News
Last Modified, April 02, 2020